in a prospective ( and continuing ) trial , a total of 271 patients with acute purulent exacerbations of chronic respiratory disease ( bacteriologically confirmed ) were treated with various new oral quinolones including enoxacin ( 26 ) , pefloxacin ( 50 ) , ciprofloxacin ( 80 ) and ofloxacin ( 115 ) .
C0034428
quinolones
C0028902
ofloxacin